ATP Working Paper Series—Working Paper 04-01
Catalyzing the Genomics Revolution: ATP's Tools for DNA Diagnostics Focused Program

SUMMARY

ATP's investment in DNA technologies, catalyzed by the creation of the Tools for DNA Diagnostics focused program, has proven to be a unique and successful industry-driven cooperative program and has had a significant impact on the Human Genome Project, the companies and industries involved in genome sequencing, and the biotechnology and diagnostics markets. It is expected that the outcome from the projects will continue to benefit U.S. society. The funding provided by ATP has allowed companies to develop high-risk technologies. New markets continue to be created, and sustainable businesses are emerging. The program's focus on a set of enabling technologies in DNA analysis provided the critical mass to overcome the challenges to raising market awareness and driving industry competitiveness. The end results of the projects funded by ATP have provided society with new ways to study and cure diseases, perform rapid tests to diagnose and manage disease, monitor the safety of food, and develop new agricultural products.

Return to Table of Contents or go to next section of working paper.

Date created: August 1, 2005
Last updated: August 5, 2005